谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Treatment with Midostaurin and Other FLT3 Targeting Inhibitors is Associated with an Increased Risk of Cardiovascular Adverse Events in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation with FLT3-mutated AML

Anjali Cremer,Julius C. Enssle, Saskia Pfaff,Khouloud Kouidri,Fabian Lang,Christian Brandts,Andreas Zeiher,Sebastian Cremer,Björn Steffen,Hubert Serve,Gesine Bug

ANNALS OF HEMATOLOGY（2023）

引用 0|浏览47
暂无评分
关键词
Allogeneic stem cell transplantation,Acute myeloid leukemia,Targeted FLT3 inhibitor therapy,Cardiac toxicities
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要